Walleye Trading
ANIP icon

Walleye Trading’s ANI Pharmaceuticals ANIP Stock Holding History

Walleye Trading’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,389
Closed -$98K – 4760
2020
Q4 		$98K Buy
+3,389
New +$97.1K ﹤0.01% 3946
2020
Q3 		– Sell
-1,866
Closed -$55.6K – 4060
2020
Q2 		$60K Buy
+1,866
New +$66.9K ﹤0.01% 3731
2019
Q3 		– Sell
-2,998
Closed -$224K – 3990
2019
Q2 		$246K Buy
2,998
+2,018
+206% +$144K ﹤0.01% 2784
2019
Q1 		$69K Buy
+980
New +$57.7K ﹤0.01% 3616
2016
Q4 		– Sell
-900
Closed -$60K – 4680
2016
Q3 		$60K Buy
+900
New +$56.3K ﹤0.01% 3647

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Walleye Trading's ANIP Position: Q1 2021 in Review

Walleye Trading sold out of ANI Pharmaceuticals (ANIP) in Q1 2021, closing a stake of 3,389 shares — an estimated $98K sold.

Walleye Trading first reported a position in ANIP in Q3 2016 and held it in 5 quarters. The position peaked at $246K in Q2 2019. 106 funds tracked by Wall St. Rank hold ANIP as of Q1 2021.

  • Walleye Trading reported no remaining ANI Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Walleye Trading sold 3,389 ANI Pharmaceuticals shares in Q1 2021, an estimated $98K.
  • Walleye Trading first reported a position in ANI Pharmaceuticals in Q3 2016 and held it in 5 quarters.
  • Walleye Trading's ANI Pharmaceuticals position peaked at $246K in Q2 2019.
  • 106 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2021.

Based on Walleye Trading's 13F filing for Q1 2021, filed 17 May 2021.